Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Human lymphoid organ cDC2 and macrophages play complementary roles in T follicular helper responses.

Durand M, Walter T, Pirnay T, Naessens T, Gueguen P, Goudot C, Lameiras S, Chang Q, Talaei N, Ornatsky O, Vassilevskaia T, Baulande S, Amigorena S, Segura E.

J Exp Med. 2019 Jul 1;216(7):1561-1581. doi: 10.1084/jem.20181994. Epub 2019 May 9.

PMID:
31072818
2.

Archeogenetics of F11 p.Cys38Arg: a 5400-year-old mutation identified in different southwestern European countries.

de la Morena-Barrio ME, Salloum-Asfar S, Esteban J, de la Morena-Barrio B, Altisent C, Martin-Fernández L, Gueguen P, Padilla J, Miñano A, Parra R, Vicente V, Vidal F, Bauduer F, Carbonell P, Corral J.

Blood. 2019 Jun 13;133(24):2618-2622. doi: 10.1182/blood.2019000055. Epub 2019 May 1. No abstract available.

PMID:
31043424
3.

An essential role for α4A-tubulin in platelet biogenesis.

Strassel C, Magiera MM, Dupuis A, Batzenschlager M, Hovasse A, Pleines I, Guéguen P, Eckly A, Moog S, Mallo L, Kimmerlin Q, Chappaz S, Strub JM, Kathiresan N, de la Salle H, Van Dorsselaer A, Ferec C, Py JY, Gachet C, Schaeffer-Reiss C, Kile BT, Janke C, Lanza F.

Life Sci Alliance. 2019 Feb 13;2(1). pii: e201900309. doi: 10.26508/lsa.201900309. Print 2019 Feb.

4.

Performance of semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidy: results from a multicenter prospective cohort study in a clinical setting.

El Khattabi LA, Brun S, Gueguen P, Chatron N, Guichoux E, Schutz S, Nectoux J, Sorlin A, Quere M, Boudjarane J, Tsatsaris V, Mandelbrot L, Schluth-Bolard C, Dupont JM, Rooryck C; H+ Consortium.

Ultrasound Obstet Gynecol. 2019 Aug;54(2):246-254. doi: 10.1002/uog.20112.

PMID:
30191619
5.

Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway.

Tang-Huau TL, Gueguen P, Goudot C, Durand M, Bohec M, Baulande S, Pasquier B, Amigorena S, Segura E.

Nat Commun. 2018 Jul 2;9(1):2570. doi: 10.1038/s41467-018-04985-0.

6.

A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite no PD-L1 Expression.

Basse V, Schick U, Guéguen P, Le Maréchal C, Quintin-Roué I, Descourt R, Simon H, Uguen A, Quéré G.

J Thorac Oncol. 2018 Jul;13(7):e120-e122. doi: 10.1016/j.jtho.2018.03.004. No abstract available.

7.

The epigenetic control of stemness in CD8+ T cell fate commitment.

Pace L, Goudot C, Zueva E, Gueguen P, Burgdorf N, Waterfall JJ, Quivy JP, Almouzni G, Amigorena S.

Science. 2018 Jan 12;359(6372):177-186. doi: 10.1126/science.aah6499.

PMID:
29326266
8.

Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus Macrophages.

Goudot C, Coillard A, Villani AC, Gueguen P, Cros A, Sarkizova S, Tang-Huau TL, Bohec M, Baulande S, Hacohen N, Amigorena S, Segura E.

Immunity. 2017 Sep 19;47(3):582-596.e6. doi: 10.1016/j.immuni.2017.08.016.

9.

ACTN1-related Macrothrombocytopenia: A Novel Entity in the Progressing Field of Pediatric Thrombocytopenia.

Boutroux H, David B, Guéguen P, Frange P, Vincenot A, Leverger G, Favier R.

J Pediatr Hematol Oncol. 2017 Nov;39(8):e515-e518. doi: 10.1097/MPH.0000000000000885.

PMID:
28562514
10.

Intragenic deletion of the WDR45 gene in a male with encephalopathy, severe psychomotor disability, and epilepsy.

Redon S, Benech C, Schutz S, Despres A, Gueguen P, Le Berre P, Le Marechal C, Peudenier S, Meriot P, Parent P, Ferec C.

Am J Med Genet A. 2017 May;173(5):1444-1446. doi: 10.1002/ajmg.a.38180. Epub 2017 Apr 3. No abstract available.

PMID:
28371320
11.

Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome.

Luque Paz D, Chauveau A, Boyer F, Buors C, Samaison L, Cottin L, Seegers V, Férec C, Le Maréchal C, Gueguen P, Lippert E, Ianotto JC, Ugo V.

Genes Chromosomes Cancer. 2017 May;56(5):354-362. doi: 10.1002/gcc.22437. Epub 2017 Feb 1.

PMID:
27997717
12.

Next generation sequencing with a semi-conductor technology (Ion Torrent PGM™) for HLA typing: overall workflow performance and debate.

Moalic-Allain V, Mercier B, Gueguen P, Ferec C.

Ann Biol Clin (Paris). 2016 Aug 1;74(4):449-56. doi: 10.1684/abc.2016.1161.

13.

A misleading false-negative result of Pneumocystis real-time PCR assay due to a rare punctual mutation: A French multicenter study.

Le Gal S, Robert-Gangneux F, Pépino Y, Belaz S, Damiani C, Guéguen P, Pitous M, Virmaux M, Lissillour E, Pougnet L, Guillaud-Saumur T, Toubas D, Valot S, Hennequin C, Morio F, Hasseine L, Bouchara JP, Totet A, Nevez G.

Med Mycol. 2017 Feb 1;55(2):180-184. doi: 10.1093/mmy/myw051. Epub 2016 Aug 3.

PMID:
27489302
14.

Nonlinear dynamics induced in a structure by seismic and environmental loading.

Guéguen P, Johnson P, Roux P.

J Acoust Soc Am. 2016 Jul;140(1):582. doi: 10.1121/1.4958990.

PMID:
27475180
15.

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues.

Uguen A, Andrieu-Key S, Vergne F, Descourt R, Quéré G, Quintin-Roué I, Key S, Guéguen P, Talagas M, De Braekeleer M, Marcorelles P.

Oncol Rep. 2016 Sep;36(3):1427-34. doi: 10.3892/or.2016.4962. Epub 2016 Jul 21.

PMID:
27460205
16.

Standardized fixation process is crucial to permit molecular analyses in formalin-fixed and paraffin-embedded melanoma samples.

Uguen A, Guibourg B, Guéguen P.

Clin Chem Lab Med. 2016 Nov 1;54(11):e359-e360. doi: 10.1515/cclm-2016-0397. No abstract available.

PMID:
27289004
17.

Is SP174 Immunohistochemistry an Interesting Ancillary Tool to Determine RAS Mutational Status in Colorectal Carcinoma?

Uguen A, Gueguen P, Guibourg B, Duigou S, Pochic M, Conq G, Samaison L, Marcorelles P, De Braekeleer M.

Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):e25-e26. doi: 10.1097/PAI.0000000000000375. No abstract available.

PMID:
27153446
18.

Forests as a natural seismic metamaterial: Rayleigh wave bandgaps induced by local resonances.

Colombi A, Roux P, Guenneau S, Gueguen P, Craster RV.

Sci Rep. 2016 Jan 11;6:19238. doi: 10.1038/srep19238.

19.

BRAF and NRAS Mutations are Not Mutually Exclusive in Melanoma and in Single Melanoma Cells.

Uguen A, Guéguen P, Talagas M, Costa S, De Braekeleer M, Marcorelles P.

Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):e14-5. doi: 10.1097/PAI.0000000000000217. No abstract available.

PMID:
26317309
20.

Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice.

Uguen A, Guéguen P, Legoupil D, Bouvier S, Costa S, Duigou S, Lemasson G, Ledé F, Sassolas B, Talagas M, Férec C, Le Maréchal C, De Braekeleer M, Marcorelles P.

Hum Pathol. 2015 Nov;46(11):1582-91. doi: 10.1016/j.humpath.2015.06.023. Epub 2015 Jul 15.

PMID:
26297254
21.

Next-Generation Sequencing and Immunohistochemistry as Future Gold Standard of ALK Testing in Lung Cancer?

Uguen A, Talagas M, Marcorelles P, Guéguen P, Costa S, Andrieu-Key S, De Braekeleer M.

Oncologist. 2015 Aug;20(8):e24. doi: 10.1634/theoncologist.2015-0123. Epub 2015 Jul 8. No abstract available.

22.

A new point mutation in EPOR inducing a short deletion in congenital erythrocytosis.

Chauveau A, Luque Paz D, Lecucq L, Le Gac G, Le Maréchal C, Gueguen P, Berthou C, Ugo V.

Br J Haematol. 2016 Feb;172(3):475-7. doi: 10.1111/bjh.13511. Epub 2015 May 26. No abstract available.

PMID:
26010769
23.

Pneumocystis jirovecii in the air surrounding patients with Pneumocystis pulmonary colonization.

Le Gal S, Pougnet L, Damiani C, Fréalle E, Guéguen P, Virmaux M, Ansart S, Jaffuel S, Couturaud F, Delluc A, Tonnelier JM, Castellant P, Le Meur Y, Le Floch G, Totet A, Menotti J, Nevez G.

Diagn Microbiol Infect Dis. 2015 Jun;82(2):137-42. doi: 10.1016/j.diagmicrobio.2015.01.004. Epub 2015 Jan 15.

PMID:
25801779
24.

AIDS-related Pneumocystis jirovecii genotypes in French Guiana.

Le Gal S, Blanchet D, Damiani C, Guéguen P, Virmaux M, Abboud P, Guillot G, Kérangart S, Merle C, Calderon E, Totet A, Carme B, Nevez G.

Infect Genet Evol. 2015 Jan;29:60-7. doi: 10.1016/j.meegid.2014.10.021. Epub 2014 Nov 5.

PMID:
25445659
25.

Structural-change localization and monitoring through a perturbation-based inverse problem.

Roux P, Guéguen P, Baillet L, Hamze A.

J Acoust Soc Am. 2014 Nov;136(5):2586-97. doi: 10.1121/1.4897403.

PMID:
25373960
26.

Next-generation sequencing is a credible strategy for blood group genotyping.

Fichou Y, Audrézet MP, Guéguen P, Le Maréchal C, Férec C.

Br J Haematol. 2014 Nov;167(4):554-62. doi: 10.1111/bjh.13084. Epub 2014 Aug 19.

PMID:
25135605
27.

Evidence for the high importance of co-morbid factors in HFE C282Y/H63D patients cared by phlebotomies: results from an observational prospective study.

Saliou P, Le Gac G, Mercier AY, Chanu B, Guéguen P, Mérour MC, Gourlaouen I, Autret S, Le Maréchal C, Rouault K, Nousbaum JB, Férec C, Scotet V.

PLoS One. 2013 Dec 5;8(12):e81128. doi: 10.1371/journal.pone.0081128. eCollection 2013.

28.

A missense mutation in the alpha-actinin 1 gene (ACTN1) is the cause of autosomal dominant macrothrombocytopenia in a large French family.

Guéguen P, Rouault K, Chen JM, Raguénès O, Fichou Y, Hardy E, Gobin E, Pan-Petesch B, Kerbiriou M, Trouvé P, Marcorelles P, Abgrall JF, Le Maréchal C, Férec C.

PLoS One. 2013 Sep 17;8(9):e74728. doi: 10.1371/journal.pone.0074728. eCollection 2013.

29.

Pneumocystis jirovecii haplotypes at the internal transcribed spacers of the rRNA operon in French HIV-negative patients with diverse clinical presentations of Pneumocystis infections.

Le Gal S, Rouille A, Gueguen P, Virmaux M, Berthou C, Guillerm G, Couturaud F, Le Meur Y, Damiani C, Totet A, Nevez G.

Med Mycol. 2013 Nov;51(8):851-62. doi: 10.3109/13693786.2013.824123. Epub 2013 Aug 22.

PMID:
23964829
30.

Revisiting the molecular epidemiology of factor XI deficiency: nine new mutations and an original large 4qTer deletion in western Brittany (France).

Guéguen P, Chauvin A, Quémener-Redon S, Pan-Petesch B, Férec C, Abgrall JF, Le Maréchal C.

Thromb Haemost. 2012 Jan;107(1):44-50. doi: 10.1160/TH11-06-0415. Epub 2011 Dec 8.

31.

Biological determinants of bleeding in patients with heterozygous factor XI deficiency.

Guéguen P, Galinat H, Blouch MT, Bridey F, Duchemin J, Le Gal G, Abgrall JF, Pan-Petesch B.

Br J Haematol. 2012 Jan;156(2):245-51. doi: 10.1111/j.1365-2141.2011.08945.x. Epub 2011 Nov 21.

PMID:
22098495
32.

Two residues in the activation peptide domain contribute to the half-life of factor X in vivo.

Guéguen P, Cherel G, Badirou I, Denis CV, Christophe OD.

J Thromb Haemost. 2010 Jul;8(7):1651-3. doi: 10.1111/j.1538-7836.2010.03905.x. Epub 2010 May 4. No abstract available.

33.

The disappearing act of factor VIII.

Lenting PJ, Christophe OD, Guéguen P.

Haemophilia. 2010 May;16(102):6-15. doi: 10.1111/j.1365-2516.2008.01864.x. Epub 2008 Sep 1. Review.

PMID:
18771423
34.

New formulae for folding catalysts make them multi-purpose enzymes.

Moutiez M, Guthapfel R, Gueguen P, Quéméneur E.

Biotechnol Bioeng. 1997 Dec 20;56(6):645-9. doi: 10.1002/(SICI)1097-0290(19971220)56:6<645::AID-BIT7>3.0.CO;2-N.

PMID:
18642336
35.

Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis.

Renaudineau Y, Dalekos GN, Guéguen P, Zachou K, Youinou P.

Clin Rev Allergy Immunol. 2008 Jun;34(3):321-5. doi: 10.1007/s12016-007-8050-1.

PMID:
18197482
36.

Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1.

Guéguen P, Dalekos G, Nousbaum JB, Zachou K, Putterman C, Youinou P, Renaudineau Y.

J Clin Immunol. 2006 Nov;26(6):495-505. Epub 2006 Sep 26.

PMID:
17001515
37.

Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.

Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Guéguen P, Hanrotel C, Gilburd B, Saraux A, Shoenfeld Y, Putterman C, Youinou P.

Arthritis Rheum. 2006 Aug;54(8):2523-32.

38.

The ananti-alpha-actinin test completes ananti-DNA determination in systemic lupus erythematosus.

Croquefer S, Renaudineau Y, Jousse S, Gueguen P, Ansart S, Saraux A, Youinou P.

Ann N Y Acad Sci. 2005 Jun;1050:170-5.

PMID:
16014531
39.

[Orthodontic preparation for orthognathic surgery. Various specific points].

De Massiac G, Gueguen P, Blanc JL, Mercier J.

Rev Stomatol Chir Maxillofac. 1998 Apr;99(1):11-9. French.

PMID:
9615348
40.

[The coral orbital floor. Its value in traumatology. The results of a multicenter study of 83 cases].

Mercier J, Piot B, Gueguen P, Cantaloube D, Blanc JL, Boutault F, Cariou JL, Devauchelle B, Pellerin P, Peri G, Ricbourg B, Stricker M, Wilk A.

Rev Stomatol Chir Maxillofac. 1996 Dec;97(6):324-31. French.

PMID:
9036516
41.

Reexamination of hormone-binding properties of protein disulfide-isomerase.

Guthapfel R, Gueguen P, Quemeneur E.

Eur J Biochem. 1996 Dec 1;242(2):315-9.

42.

ATP binding and hydrolysis by the multifunctional protein disulfide isomerase.

Guthapfel R, Guéguen P, Quéméneur E.

J Biol Chem. 1996 Feb 2;271(5):2663-6.

43.

A major phosphoprotein of the endoplasmic reticulum is protein disulfide isomerase.

Quéméneur E, Guthapfel R, Gueguen P.

J Biol Chem. 1994 Feb 25;269(8):5485-8.

44.
45.

C-terminal labelling of beta-casein.

Carles C, Gueguen P, Ribadeau-Dumas B.

FEBS Lett. 1987 Feb 9;212(1):163-7.

46.

Incorporation of amino acid analogs during the biosynthesis of Escherichia coli aspartate transcarbamylase.

Gueguen P, Padron M, Perbal B, Hervé G.

Biochim Biophys Acta. 1980 Sep 9;615(1):59-69.

PMID:
7000192
47.
48.

Hydrolyse des aminoacyl-tARN par la phosphodiesterase du venin.

Yot P, Gueguen P, Chapeville F.

FEBS Lett. 1968 Aug;1(3):156-158. French.

49.

[The situation of the dramatic arts; tragedy].

GUEGUEN P.

Psyche Rev Int Sci Homme Psychanal. 1950 Mar;5(41):277-85. Undetermined Language. No abstract available.

PMID:
15424279

Supplemental Content

Loading ...
Support Center